Peter Vanderslice, PhD

Dr. Vanderslice has spent over 20 years leading teams focused on the development of small molecule compounds that bind and modulate the function of integrins and chemokine receptors. The majority of his professional career has been in the pharmaceutical industry, where he gained familiarity with each stage of the pipeline from discovery to progression into clinical trials. Dr. Vanderslice has led teams working on several pre-clinical programs involving efforts in drug screening, lead compound characterization, and the development of preclinical animal models.

See Publications

Texas Heart Institute Positions

Interests

  • Non-invasive diagnostic imaging technologies

Education

  • Undergraduate:

    University of Maryland

  • Postgraduate:

    University of Texas at Austin (PhD)

  • Fellowships:

    University of California San Francisco

Honors, Awards and Memberships

Publications

4862227 BBMMGS3D 1 alternatives-to-animal-experimentation 10 date desc Vanderslice 2145 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%225FM49INS%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guan%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-28%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuan%2C%20Y.-S.%2C%20Ershad%2C%20F.%2C%20Rao%2C%20Z.%20et%20al.%20%282022%29.%20Elastic%20electronics%20based%20on%20micromesh-structured%20rubbery%20semiconductor%20films.%20%26lt%3Bi%26gt%3BNat%20Electron%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41928-022-00874-z%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41928-022-00874-z%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Elastic%20electronics%20based%20on%20micromesh-structured%20rubbery%20semiconductor%20films%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ying-Shi%22%2C%22lastName%22%3A%22Guan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faheem%22%2C%22lastName%22%3A%22Ershad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhoulyu%22%2C%22lastName%22%3A%22Rao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhifan%22%2C%22lastName%22%3A%22Ke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernesto%20Curty%22%2C%22lastName%22%3A%22da%20Costa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qian%22%2C%22lastName%22%3A%22Xiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuntao%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jianguo%22%2C%22lastName%22%3A%22Mei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camila%22%2C%22lastName%22%3A%22Hochman-Mendez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cunjiang%22%2C%22lastName%22%3A%22Yu%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Nov%2028%202022%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41928-022-00874-z%22%2C%22ISSN%22%3A%222520-1131%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41928-022-00874-z%22%2C%22collections%22%3A%5B%22BBMMGS3D%22%2C%22MJL5PY3A%22%2C%229T6HXJUI%22%2C%2235JIYMYN%22%2C%22QF52JASW%22%5D%2C%22dateModified%22%3A%222022-12-01T19%3A16%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22W3T5H5J2%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mendiola%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-17%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMendiola%2C%20E.%20A.%2C%20Neelakantan%2C%20S.%2C%20Xiang%2C%20Q.%20et%20al.%20%282022%29.%20Contractile%20adaptation%20of%20the%20left%20ventricle%20post-myocardial%20infarction%3A%20predictions%20by%20rodent-specific%20computational%20modeling.%20%26lt%3Bi%26gt%3BAnn%20Biomed%20Eng%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10439-022-03102-z%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10439-022-03102-z%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Contractile%20adaptation%20of%20the%20left%20ventricle%20post-myocardial%20infarction%3A%20predictions%20by%20rodent-specific%20computational%20modeling%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilio%20A.%22%2C%22lastName%22%3A%22Mendiola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunder%22%2C%22lastName%22%3A%22Neelakantan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qian%22%2C%22lastName%22%3A%22Xiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samer%22%2C%22lastName%22%3A%22Merchant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ke%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20W.%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reza%22%2C%22lastName%22%3A%22Avazmohammadi%22%7D%5D%2C%22abstractNote%22%3A%22Myocardial%20infarction%20%28MI%29%20results%20in%20cardiac%20myocyte%20death%20and%20the%20formation%20of%20a%20fibrotic%20scar%20in%20the%20left%20ventricular%20free%20wall%20%28LVFW%29.%20Following%20an%20acute%20MI%2C%20LVFW%20remodeling%20takes%20place%20consisting%20of%20several%20alterations%20in%20the%20structure%20and%20properties%20of%20cellular%20and%20extracellular%20components%20with%20a%20heterogeneous%20pattern%20across%20the%20LVFW.%20The%20normal%20function%20of%20the%20heart%20is%20strongly%20influenced%20by%20the%20passive%20and%20active%20biomechanical%20behavior%20of%20the%20LVFW%2C%20and%20progressive%20myocardial%20structural%20remodeling%20can%20have%20a%20detrimental%20effect%20on%20both%20diastolic%20and%20systolic%20functions%20of%20the%20LV%20leading%20to%20heart%20failure.%20Despite%20important%20advances%20in%20understanding%20LVFW%20passive%20remodeling%20in%20the%20setting%20of%20MI%2C%20heterogeneous%20remodeling%20in%20the%20LVFW%20active%20properties%20and%20its%20relationship%20to%20organ-level%20LV%20function%20remain%20understudied.%20To%20address%20these%20gaps%2C%20we%20developed%20high-fidelity%20finite-element%20%28FE%29%20rodent%20computational%20cardiac%20models%20%28RCCMs%29%20of%20MI%20using%20extensive%20datasets%20from%20MI%20rat%20hearts%20representing%20the%20heart%20remodeling%20from%20one-week%20%281-wk%29%20to%20four-week%20%284-wk%29%20post-MI%20timepoints.%20The%20rat-specific%20models%20%28n%20%3D%202%20for%20each%20timepoint%29%20integrate%20detailed%20imaging%20data%20of%20the%20heart%20geometry%2C%20myocardial%20fiber%20architecture%2C%20and%20infarct%20zone%20determined%20using%20late%20gadolinium%20enhancement%20prior%20to%20terminal%20measurements.%20The%20computational%20models%20predicted%20a%20significantly%20higher%20level%20of%20active%20tension%20in%20remote%20myocardium%20in%20early%20post-MI%20hearts%20%281-wk%20post-MI%29%20followed%20by%20a%20return%20to%20near%20the%20control%20level%20in%20late-stage%20MI%20%283-%20and%204-wk%20post-MI%29.%20The%20late-stage%20MI%20rats%20showed%20smaller%20myofiber%20ranges%20in%20the%20remote%20region%20and%20in-silico%20experiments%20using%20RCCMs%20suggested%20that%20the%20smaller%20fiber%20helicity%20is%20consistent%20with%20lower%20contractile%20forces%20needed%20to%20meet%20the%20measured%20ejection%20fractions%20in%20late-stage%20MI.%20In%20contrast%2C%20in-silico%20experiments%20predicted%20that%20collagen%20fiber%20transmural%20orientation%20in%20the%20infarct%20region%20has%20little%20influence%20on%20organ-level%20function.%20In%20addition%2C%20our%20MI%20RCCMs%20indicated%20that%20reduced%20and%20potentially%20positive%20circumferential%20strains%20in%20the%20infarct%20region%20at%20end-systole%20can%20be%20used%20to%20infer%20information%20about%20the%20time-varying%20properties%20of%20the%20infarct%20region.%20The%20detailed%20description%20of%20regional%20passive%20and%20active%20remodeling%20patterns%20can%20complement%20and%20enhance%20the%20traditional%20measures%20of%20LV%20anatomy%20and%20function%20that%20often%20lead%20to%20a%20gross%20and%20limited%20assessment%20of%20cardiac%20performance.%20The%20translation%20and%20implementation%20of%20our%20model%20in%20patient-specific%20organ-level%20simulations%20offer%20to%20advance%20the%20investigation%20of%20individualized%20prognosis%20and%20intervention%20for%20MI.%22%2C%22date%22%3A%22Nov%2017%2C%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10439-022-03102-z%22%2C%22ISSN%22%3A%221573-9686%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%22BBMMGS3D%22%2C%2242FKW3I4%22%2C%229T6HXJUI%22%2C%22TXW6RMW4%22%5D%2C%22dateModified%22%3A%222023-01-06T17%3A13%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22I7XSBSGG%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hickman%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHickman%2C%20A.%2C%20Koetsier%2C%20J.%2C%20Kurtanich%2C%20T.%20et%20al.%20%282022%29.%20LFA-1%20activation%20enriches%20tumor-specific%20T%20cells%20in%20a%20cold%20tumor%20model%20and%20synergizes%20with%20CTLA-4%20blockade.%20%26lt%3Bi%26gt%3BJ%20Clin%20Invest%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B132%26lt%3B%5C%2Fi%26gt%3B%2C%20e154152.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2FJCI154152%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2FJCI154152%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22LFA-1%20activation%20enriches%20tumor-specific%20T%20cells%20in%20a%20cold%20tumor%20model%20and%20synergizes%20with%20CTLA-4%20blockade%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amber%22%2C%22lastName%22%3A%22Hickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joost%22%2C%22lastName%22%3A%22Koetsier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trevin%22%2C%22lastName%22%3A%22Kurtanich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20C.%22%2C%22lastName%22%3A%22Nielsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glenn%22%2C%22lastName%22%3A%22Winn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yunfei%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salah-Eddine%22%2C%22lastName%22%3A%22Bentebibel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leilei%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%22%2C%22lastName%22%3A%22Punt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leila%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cara%22%2C%22lastName%22%3A%22Haymaker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20B.%22%2C%22lastName%22%3A%22Chesson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%22%2C%22lastName%22%3A%22Fa%27ak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20L.%22%2C%22lastName%22%3A%22Dominguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isere%22%2C%22lastName%22%3A%22Kuiatse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20R.%22%2C%22lastName%22%3A%22Caivano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayadeth%22%2C%22lastName%22%3A%22Khounlo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Navin%20D.%22%2C%22lastName%22%3A%22Warier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Upendra%22%2C%22lastName%22%3A%22Marathi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20V.%22%2C%22lastName%22%3A%22Market%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20J.%22%2C%22lastName%22%3A%22Biediger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20W.%22%2C%22lastName%22%3A%22Craft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Hwu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20A.%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adi%22%2C%22lastName%22%3A%22Diab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Willem%20W.%22%2C%22lastName%22%3A%22Overwijk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yared%22%2C%22lastName%22%3A%22Hailemichael%22%7D%5D%2C%22abstractNote%22%3A%22The%20inability%20of%20CD8%2B%20effector%20T%20cells%20%28Teffs%29%20to%20reach%20tumor%20cells%20is%20an%20important%20aspect%20of%20tumor%20resistance%20to%20cancer%20immunotherapy.%20The%20recruitment%20of%20these%20cells%20to%20the%20tumor%20microenvironment%20%28TME%29%20is%20regulated%20by%20integrins%2C%20a%20family%20of%20adhesion%20molecules%20that%20are%20expressed%20on%20T%20cells.%20Here%2C%20we%20show%20that%207HP349%2C%20a%20small-molecule%20activator%20of%20lymphocyte%20function-associated%20antigen-1%20%28LFA-1%29%20and%20very%20late%20activation%20antigen-4%20%28VLA-4%29%20integrin%20cell-adhesion%20receptors%2C%20facilitated%20the%20preferential%20localization%20of%20tumor-specific%20T%20cells%20to%20the%20tumor%20and%20improved%20antitumor%20response.%207HP349%20monotherapy%20had%20modest%20effects%20on%20anti-programmed%20death%201-resistant%20%28anti-PD-1-resistant%29%20tumors%2C%20whereas%20combinatorial%20treatment%20with%20anti-cytotoxic%20T%20lymphocyte-associated%20protein%204%20%28anti-CTLA-4%29%20increased%20CD8%2B%20Teff%20intratumoral%20sequestration%20and%20synergized%20in%20cooperation%20with%20neutrophils%20in%20inducing%20cancer%20regression.%207HP349%20intratumoral%20CD8%2B%20Teff%20enrichment%20activity%20depended%20on%20CXCL12.%20We%20analyzed%20gene%20expression%20profiles%20using%20RNA%20from%20baseline%20and%20on%20treatment%20tumor%20samples%20of%2014%20melanoma%20patients.%20We%20identified%20baseline%20CXCL12%20gene%20expression%20as%20possibly%20improving%20the%20likelihood%20or%20response%20to%20anti-CTLA-4%20therapies.%20Our%20results%20provide%20a%20proof-of-principle%20demonstration%20that%20LFA-1%20activation%20could%20convert%20a%20T%20cell-exclusionary%20TME%20to%20a%20T%20cell-enriched%20TME%20through%20mechanisms%20involving%20cooperation%20with%20innate%20immune%20cells.%22%2C%22date%22%3A%22July%2001%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1172%5C%2FJCI154152%22%2C%22ISSN%22%3A%221558-8238%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%226MADD4J5%22%2C%22BBMMGS3D%22%2C%227XFQVVGN%22%2C%224R4R39JD%22%2C%227STYFUFZ%22%2C%225QIRWFUY%22%2C%22TC3LQMP8%22%2C%222RCWVZ4F%22%5D%2C%22dateModified%22%3A%222022-08-02T14%3A41%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22V95W4SUL%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Babaei%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-31%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBabaei%2C%20H.%2C%20Mendiola%2C%20E.%20A.%2C%20Neelakantan%2C%20S.%20et%20al.%20%282022%29.%20A%20machine%20learning%20model%20to%20estimate%20myocardial%20stiffness%20from%20EDPVR.%20%26lt%3Bi%26gt%3BSci%20Rep%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B%2C%205433.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-022-09128-6%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-022-09128-6%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20machine%20learning%20model%20to%20estimate%20myocardial%20stiffness%20from%20EDPVR%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hamed%22%2C%22lastName%22%3A%22Babaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilio%20A.%22%2C%22lastName%22%3A%22Mendiola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunder%22%2C%22lastName%22%3A%22Neelakantan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qian%22%2C%22lastName%22%3A%22Xiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Vang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dipan%20J.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaurav%22%2C%22lastName%22%3A%22Choudhary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reza%22%2C%22lastName%22%3A%22Avazmohammadi%22%7D%5D%2C%22abstractNote%22%3A%22In-vivo%20estimation%20of%20mechanical%20properties%20of%20the%20myocardium%20is%20essential%20for%20patient-specific%20diagnosis%20and%20prognosis%20of%20cardiac%20disease%20involving%20myocardial%20remodeling%2C%20including%20myocardial%20infarction%20and%20heart%20failure%20with%20preserved%20ejection%20fraction.%20Current%20approaches%20use%20time-consuming%20finite-element%20%28FE%29%20inverse%20methods%20that%20involve%20reconstructing%20and%20meshing%20the%20heart%20geometry%2C%20imposing%20measured%20loading%2C%20and%20conducting%20computationally%20expensive%20iterative%20FE%20simulations.%20In%20this%20paper%2C%20we%20propose%20a%20machine%20learning%20%28ML%29%20model%20that%20feasibly%20and%20accurately%20predicts%20passive%20myocardial%20properties%20directly%20from%20select%20geometric%2C%20architectural%2C%20and%20hemodynamic%20measures%2C%20thus%20bypassing%20exhaustive%20steps%20commonly%20required%20in%20cardiac%20FE%20inverse%20problems.%20Geometric%20and%20fiber-orientation%20features%20were%20chosen%20to%20be%20readily%20obtainable%20from%20standard%20cardiac%20imaging%20protocols.%20The%20end-diastolic%20pressure-volume%20relationship%20%28EDPVR%29%2C%20which%20can%20be%20obtained%20using%20a%20single-point%20pressure-volume%20measurement%2C%20was%20used%20as%20a%20hemodynamic%20%28loading%29%20feature.%20A%20comprehensive%20ML%20training%20dataset%20in%20the%20geometry-architecture-loading%20space%20was%20generated%2C%20including%20a%20wide%20variety%20of%20partially%20synthesized%20rodent%20heart%20geometry%20and%20myofiber%20helicity%20possibilities%2C%20and%20a%20broad%20range%20of%20EDPVRs%20obtained%20using%20forward%20FE%20simulations.%20Latin%20hypercube%20sampling%20was%20used%20to%20create%202500%20examples%20for%20training%2C%20validation%2C%20and%20testing.%20A%20multi-layer%20feed-forward%20neural%20network%20%28MFNN%29%20was%20used%20as%20a%20deep%20learning%20agent%20to%20train%20the%20ML%20model.%20The%20model%20showed%20excellent%20performance%20in%20predicting%20stiffness%20parameters%20%5BFormula%3A%20see%20text%5D%20and%20%5BFormula%3A%20see%20text%5D%20associated%20with%20fiber%20direction%20%28%5BFormula%3A%20see%20text%5D%20and%20%5BFormula%3A%20see%20text%5D%29.%20After%20conducting%20permutation%20feature%20importance%20analysis%2C%20the%20ML%20performance%20further%20improved%20for%20%5BFormula%3A%20see%20text%5D%20%28%5BFormula%3A%20see%20text%5D%29%2C%20and%20the%20left%20ventricular%20volume%20and%20endocardial%20area%20were%20found%20to%20be%20the%20most%20critical%20geometric%20features%20for%20accurate%20predictions.%20The%20ML%20model%20predictions%20were%20evaluated%20further%20in%20two%20cases%3A%20%28i%29%20rat-specific%20stiffness%20data%20measured%20using%20ex-vivo%20mechanical%20testing%2C%20and%20%28ii%29%20patient-specific%20estimation%20using%20FE%20inverse%20modeling.%20Excellent%20agreements%20with%20ML%20predictions%20were%20found%20for%20both%20cases.%20The%20trained%20ML%20model%20offers%20a%20feasible%20technology%20to%20estimate%20patient-specific%20myocardial%20properties%2C%20thus%2C%20bridging%20the%20gap%20between%20EDPVR%2C%20as%20a%20confounded%20organ-level%20metric%20for%20tissue%20stiffness%2C%20and%20intrinsic%20tissue-level%20properties.%20These%20properties%20provide%20incremental%20information%20relative%20to%20traditional%20organ-level%20indices%20for%20cardiac%20function%2C%20improving%20the%20clinical%20assessment%20and%20prognosis%20of%20cardiac%20diseases.%22%2C%22date%22%3A%22Mar%2031%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-022-09128-6%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%22BBMMGS3D%22%2C%229T6HXJUI%22%2C%22ZH6PLEMG%22%5D%2C%22dateModified%22%3A%222022-05-04T15%3A31%3A48Z%22%7D%7D%2C%7B%22key%22%3A%227TUX9HBZ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lokugamage%20et%20al.%22%2C%22parsedDate%22%3A%222021-09-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLokugamage%2C%20N.%2C%20Chowdhury%2C%20I.%20H.%2C%20Biediger%2C%20R.%20J.%20et%20al.%20%282021%29.%20Use%20of%20a%20small%20molecule%20integrin%20activator%20as%20a%20systemically%20administered%20vaccine%20adjuvant%20in%20controlling%20Chagas%20disease.%20%26lt%3Bi%26gt%3BNPJ%20Vaccines%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B6%26lt%3B%5C%2Fi%26gt%3B%2C%20114.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41541-021-00378-5%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41541-021-00378-5%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Use%20of%20a%20small%20molecule%20integrin%20activator%20as%20a%20systemically%20administered%20vaccine%20adjuvant%20in%20controlling%20Chagas%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nandadeva%22%2C%22lastName%22%3A%22Lokugamage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Imran%20H.%22%2C%22lastName%22%3A%22Chowdhury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20J.%22%2C%22lastName%22%3A%22Biediger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20V.%22%2C%22lastName%22%3A%22Market%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayadeth%22%2C%22lastName%22%3A%22Khounlo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Navin%20D.%22%2C%22lastName%22%3A%22Warier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shen-An%22%2C%22lastName%22%3A%22Hwang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20K.%22%2C%22lastName%22%3A%22Actor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Upendra%22%2C%22lastName%22%3A%22Marathi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nisha%20Jain%22%2C%22lastName%22%3A%22Garg%22%7D%5D%2C%22abstractNote%22%3A%22The%20development%20of%20suitable%20safe%20adjuvants%20to%20enhance%20appropriate%20antigen-driven%20immune%20responses%20remains%20a%20challenge.%20Here%20we%20describe%20the%20adjuvant%20properties%20of%20a%20small%20molecule%20activator%20of%20the%20integrins%20%5Cu03b1L%5Cu03b22%20and%20%5Cu03b14%5Cu03b21%2C%20named%207HP349%2C%20which%20can%20be%20safely%20delivered%20systemically%20independent%20of%20antigen.%207HP349%20directly%20activates%20integrin%20cell%20adhesion%20receptors%20crucial%20for%20the%20generation%20of%20an%20immune%20response.%20When%20delivered%20systemically%20in%20a%20model%20of%20Chagas%20disease%20following%20immunization%20with%20a%20DNA%20subunit%20vaccine%20encoding%20candidate%20T.%20cruzi%20antigens%2C%20TcG2%20and%20TcG4%2C%207HP349%20enhanced%20the%20vaccine%20efficacy%20in%20both%20prophylactic%20and%20therapeutic%20settings.%20In%20a%20prophylactic%20setting%2C%20mice%20immunized%20with%207HP349%20adjuvanted%20vaccine%20exhibited%20significantly%20improved%20control%20of%20acute%20parasite%20burden%20in%20cardiac%20and%20skeletal%20muscle%20as%20compared%20to%20vaccination%20alone.%20When%20administered%20with%20vaccine%20therapeutically%2C%20parasite%20burden%20was%20again%20decreased%2C%20with%20the%20greatest%20adjuvant%20effect%20of%207HP349%20being%20noted%20in%20skeletal%20muscle.%20In%20both%20settings%2C%20adjuvantation%20with%207HP349%20was%20effective%20in%20decreasing%20pathological%20inflammatory%20infiltrate%2C%20improving%20the%20integrity%20of%20tissue%2C%20and%20controlling%20tissue%20fibrosis%20in%20the%20heart%20and%20skeletal%20muscle%20of%20acutely%20and%20chronically%20infected%20Chagas%20mice.%20The%20positive%20effects%20correlated%20with%20increased%20splenic%20frequencies%20of%20CD8%2BT%20effector%20cells%20and%20an%20increase%20in%20the%20production%20of%20IFN-%5Cu03b3%20and%20cytolytic%20molecules%20%28perforin%20and%20granzyme%29%20by%20the%20CD4%2B%20and%20CD8%2B%20effector%20and%20central%20memory%20subsets%20in%20response%20to%20challenge%20infection.%20This%20demonstrates%20that%207HP349%20can%20serve%20as%20a%20systemically%20administered%20adjuvant%20to%20enhance%20T%20cell-mediated%20immune%20responses%20to%20vaccines.%20This%20approach%20could%20be%20applied%20to%20numerous%20vaccines%20with%20no%20reformulation%20of%20existing%20stockpiles.%22%2C%22date%22%3A%22Sept%2008%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41541-021-00378-5%22%2C%22ISSN%22%3A%222059-0105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%226MADD4J5%22%2C%22BBMMGS3D%22%2C%227XFQVVGN%22%2C%227STYFUFZ%22%2C%225QIRWFUY%22%2C%22TC3LQMP8%22%5D%2C%22dateModified%22%3A%222021-10-07T18%3A11%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22HH4AD2YI%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bakthavatsalam%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBakthavatsalam%2C%20D.%2C%20Craft%2C%20J.%20W.%2C%20Kazansky%2C%20A.%20et%20al.%20%282020%29.%20Identification%20of%20Inhibitors%20of%20Integrin%20Cytoplasmic%20Domain%20Interactions%20With%20Syk.%20%26lt%3Bi%26gt%3BFront%20Immunol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%2C%20575085.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2020.575085%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2020.575085%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Identification%20of%20Inhibitors%20of%20Integrin%20Cytoplasmic%20Domain%20Interactions%20With%20Syk%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deenadayalan%22%2C%22lastName%22%3A%22Bakthavatsalam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20W.%22%2C%22lastName%22%3A%22Craft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Kazansky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nghi%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Goeun%22%2C%22lastName%22%3A%22Bae%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20R.%22%2C%22lastName%22%3A%22Caivano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Gundlach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asra%22%2C%22lastName%22%3A%22Aslam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Safa%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shashikant%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%20Y.%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hema%20D.%22%2C%22lastName%22%3A%22Parthiban%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifford%20C.%22%2C%22lastName%22%3A%22Stephan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%5D%2C%22abstractNote%22%3A%22Leukocyte%20inflammatory%20responses%20require%20integrin%20cell-adhesion%20molecule%20signaling%20through%20spleen%20tyrosine%20kinase%20%28Syk%29%2C%20a%20non-receptor%20kinase%20that%20binds%20directly%20to%20integrin%20%5Cu03b2-chain%20cytoplasmic%20domains.%20Here%2C%20we%20developed%20a%20high-throughput%20screen%20to%20identify%20small%20molecule%20inhibitors%20of%20the%20Syk-integrin%20cytoplasmic%20domain%20interactions.%20Screening%20small%20molecule%20compound%20libraries%20identified%20the%20%5Cu03b2-lactam%20antibiotics%20cefsulodin%20and%20ceftazidime%2C%20which%20inhibited%20integrin%20%5Cu03b2-subunit%20cytoplasmic%20domain%20binding%20to%20the%20tandem%20SH2%20domains%20of%20Syk%20%28IC50%20range%2C%201.02-4.9%20%5Cu00b5M%29.%20Modeling%20suggested%20antagonist%20binding%20to%20Syk%20outside%20the%20pITAM%20binding%20site.%20Ceftazidime%20inhibited%20integrin%20signaling%20via%20Syk%2C%20including%20inhibition%20of%20adhesion-dependent%20upregulation%20of%20interleukin-1%5Cu03b2%20and%20monocyte%20chemoattractant%20protein-1%2C%20but%20did%20not%20inhibit%20ITAM-dependent%20phosphorylation%20of%20Syk%20mediated%20by%20Fc%5Cu03b3RI%20signaling.%20Our%20results%20demonstrate%20a%20novel%20means%20to%20target%20Syk%20independent%20of%20its%20kinase%20and%20pITAM%20binding%20sites%20such%20that%20integrin%20signaling%20via%20this%20kinase%20is%20abrogated%20but%20ITAM-dependent%20signaling%20remains%20intact.%20As%20integrin%20signaling%20through%20Syk%20is%20essential%20for%20leukocyte%20activation%2C%20this%20may%20represent%20a%20novel%20approach%20to%20target%20inflammation.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2020.575085%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BBMMGS3D%22%2C%227XFQVVGN%22%2C%22VXDM6BAE%22%2C%224R4R39JD%22%2C%22XCUHKMZU%22%5D%2C%22dateModified%22%3A%222021-02-11T18%3A41%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22TKY84XFT%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Avazmohammadi%20et%20al.%22%2C%22parsedDate%22%3A%222019-07-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAvazmohammadi%2C%20R.%2C%20Mendiola%2C%20E.%2C%20Li%2C%20D.%20et%20al.%20%282019%29.%20Interactions%20between%20structural%20remodeling%20and%20volumetric%20growth%20in%20right%20ventricle%20in%20response%20to%20pulmonary%20arterial%20hypertension.%20%26lt%3Bi%26gt%3BJ%20Biomech%20Eng%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1115%5C%2F1.4044174%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1115%5C%2F1.4044174%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Interactions%20between%20structural%20remodeling%20and%20volumetric%20growth%20in%20right%20ventricle%20in%20response%20to%20pulmonary%20arterial%20hypertension%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reza%22%2C%22lastName%22%3A%22Avazmohammadi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilio%22%2C%22lastName%22%3A%22Mendiola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Sacks%22%7D%5D%2C%22abstractNote%22%3A%22Pulmonary%20arterial%20hypertension%20%28PAH%29%20exerts%20substantial%20pressure%20overload%20on%20the%20right%20ventricle%20%28RV%29.%20The%20associated%20RV%20free%20wall%20%28RVFW%29%20adaptation%20could%20consist%20of%20myocardial%20hypertrophy%2C%20augmented%20intrinsic%20contractility%2C%20collagen%20fibrosis%2C%20and%20structural%20remodeling%20in%20an%20attempt%20to%20cope%20with%20pressure%20overload.%20If%20RVFW%20adaptation%20cannot%20maintain%20the%20RV%20stroke%20volume%2C%20RV%20dilation%20will%20prevail%20as%20an%20exit%20mechanism%20which%20usually%20decompensates%20the%20RV%20function%20leading%20to%20RV%20failure.%20Our%20knowledge%20of%20the%20factors%20determining%20the%20transition%20from%20the%20upper%20limit%20of%20RVFW%20adaptation%20to%20RV%20decompensation%20and%20the%20role%20of%20fiber%20remodeling%20events%20in%20this%20transition%20remains%20very%20limited.%20Computational%20heart%20models%20that%20connect%20the%20growth%20and%20remodeling%20%28G%5C%5C%26amp%3BR%29%20events%20at%20the%20fiber%20and%20tissue%20levels%20with%20alterations%20in%20the%20organ-level%20function%20are%20essential%20to%20predict%20the%20temporal%20order%20and%20the%20compensatory%20level%20of%20the%20underlying%20mechanisms.%20In%20this%20work%2C%20building%20upon%20our%20recent%20rodent%20heart%20models%20%28RHM%29%20of%20PAH%2C%20we%20integrated%20mathematical%20models%20that%20describe%20time-evolution%20volumetric%20growth%20of%20the%20RV%20and%20structural%20remodeling%20of%20the%20RVFW.%20Results%20suggest%20that%20augmentation%20of%20the%20intrinsic%20contractility%20of%20myofibers%20accompanied%20by%20an%20increase%20in%20passive%20stiffness%20of%20RVFW%20is%20among%20the%20first%20remodeling%20events%20through%20which%20the%20RV%20strives%20to%20maintain%20the%20cardiac%20output.%20Interestingly%2C%20we%20found%20that%20the%20observed%20reorientation%20of%20the%20myofibers%20towards%20the%20longitudinal%20%28apex-to-base%29%20direction%20was%20a%20maladaptive%20mechanism%20that%20impaired%20the%20contractile%20pattern%20of%20RVFW%20and%20advanced%20along%20with%20RV%20dilation%20at%20later%20stages%20of%20PAH%20development.%22%2C%22date%22%3A%22July%201%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1115%5C%2F1.4044174%22%2C%22ISSN%22%3A%221528-8951%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%22BBMMGS3D%22%5D%2C%22dateModified%22%3A%222021-07-20T19%3A31%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22S3VJSTKJ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Avazmohammadi%20et%20al.%22%2C%22parsedDate%22%3A%222019-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAvazmohammadi%2C%20R.%2C%20Mendiola%2C%20E.%20A.%2C%20Soares%2C%20J.%20S.%20et%20al.%20%282019%29.%20A%20computational%20cardiac%20model%20for%20the%20adaptation%20to%20pulmonary%20arterial%20hypertension%20in%20the%20rat.%20%26lt%3Bi%26gt%3BAnn%20Biomed%20Eng%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B47%26lt%3B%5C%2Fi%26gt%3B%2C%20138%26%23x2013%3B153.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10439-018-02130-y%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10439-018-02130-y%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20computational%20cardiac%20model%20for%20the%20adaptation%20to%20pulmonary%20arterial%20hypertension%20in%20the%20rat%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reza%22%2C%22lastName%22%3A%22Avazmohammadi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilio%20A.%22%2C%22lastName%22%3A%22Mendiola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%5Cu00e3o%20S.%22%2C%22lastName%22%3A%22Soares%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20S.%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhiqiang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samer%22%2C%22lastName%22%3A%22Merchant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20W.%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Sacks%22%7D%5D%2C%22abstractNote%22%3A%22Pulmonary%20arterial%20hypertension%20%28PAH%29%20imposes%20pressure%20overload%20on%20the%20right%20ventricle%20%28RV%29%2C%20leading%20to%20RV%20enlargement%20via%20the%20growth%20of%20cardiac%20myocytes%20and%20remodeling%20of%20the%20collagen%20fiber%20architecture.%20The%20effects%20of%20these%20alterations%20on%20the%20functional%20behavior%20of%20the%20right%20ventricular%20free%20wall%20%28RVFW%29%20and%20organ-level%20cardiac%20function%20remain%20largely%20unexplored.%20Computational%20heart%20models%20in%20the%20rat%20%28RHMs%29%20of%20the%20normal%20and%20hypertensive%20states%20can%20be%20quite%20valuable%20in%20simulating%20the%20effects%20of%20PAH%20on%20cardiac%20function%20to%20gain%20insights%20into%20the%20pathophysiology%20of%20underlying%20myocardium%20remodeling.%20We%20thus%20developed%20high-fidelity%20biventricular%20finite%20element%20RHMs%20for%20the%20normal%20and%20post-PAH%20hypertensive%20states%20using%20extensive%20experimental%20data%20collected%20from%20rat%20hearts.%20We%20then%20applied%20the%20RHM%20to%20investigate%20the%20transmural%20nature%20of%20RVFW%20remodeling%20and%20its%20connection%20to%20wall%20stress%20elevation%20under%20PAH.%20We%20found%20a%20strong%20correlation%20between%20the%20longitudinally-dominated%20fiber-level%20adaptation%20of%20the%20RVFW%20and%20the%20transmural%20alterations%20of%20relevant%20wall%20stress%20components.%20We%20further%20conducted%20several%20numerical%20experiments%20to%20gain%20new%20insights%20on%20how%20the%20RV%20responds%20both%20normally%20and%20in%20the%20post-PAH%20state.%20We%20found%20that%20the%20effect%20of%20pressure%20overload%20alone%20on%20the%20increased%20contractility%20of%20the%20RV%20is%20comparable%20to%20the%20effects%20of%20changes%20in%20the%20RV%20geometry%20and%20stiffness.%20Furthermore%2C%20our%20RHMs%20provided%20fresh%20perspectives%20on%20long-standing%20questions%20of%20the%20functional%20role%20of%20the%20interventricular%20septum%20in%20RV%20function.%20Specifically%2C%20we%20demonstrated%20that%20an%20inaccurate%20identification%20of%20the%20mechanical%20adaptation%20of%20the%20septum%20can%20lead%20to%20a%20significant%20underestimation%20of%20RVFW%20contractility%20in%20the%20post-PAH%20state.%20These%20findings%20show%20how%20integrated%20experimental-computational%20models%20can%20facilitate%20a%20more%20comprehensive%20understanding%20of%20the%20cardiac%20remodeling%20events%20during%20PAH.%22%2C%22date%22%3A%22Jan%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10439-018-02130-y%22%2C%22ISSN%22%3A%221573-9686%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%22BBMMGS3D%22%2C%22HXM4WGQT%22%5D%2C%22dateModified%22%3A%222019-03-06T21%3A09%3A27Z%22%7D%7D%2C%7B%22key%22%3A%229LRIQ9XJ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Woodside%20et%20al.%22%2C%22parsedDate%22%3A%222018-02-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWoodside%2C%20D.%20G.%2C%20Tanifum%2C%20E.%20A.%2C%20Ghaghada%2C%20K.%20B.%20et%20al.%20%282018%29.%20Magnetic%20resonance%20imaging%20of%20atherosclerotic%20plaque%20at%20clinically%20relevant%20field%20strengths%20%281T%29%20by%20targeting%20the%20integrin%20%26%23x3B1%3B4%26%23x3B2%3B1.%20%26lt%3Bi%26gt%3BSci%20Rep%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%203733.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-018-21893-x%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-018-21893-x%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Magnetic%20resonance%20imaging%20of%20atherosclerotic%20plaque%20at%20clinically%20relevant%20field%20strengths%20%281T%29%20by%20targeting%20the%20integrin%20%5Cu03b14%5Cu03b21%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20A.%22%2C%22lastName%22%3A%22Tanifum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ketan%20B.%22%2C%22lastName%22%3A%22Ghaghada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20J.%22%2C%22lastName%22%3A%22Biediger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20R.%22%2C%22lastName%22%3A%22Caivano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zbigniew%20A.%22%2C%22lastName%22%3A%22Starosolski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayadeth%22%2C%22lastName%22%3A%22Khounlo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saakshi%22%2C%22lastName%22%3A%22Bhayana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shahrzad%22%2C%22lastName%22%3A%22Abbasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20W.%22%2C%22lastName%22%3A%22Craft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20S.%22%2C%22lastName%22%3A%22Maxwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chandreshkumar%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%20V.%22%2C%22lastName%22%3A%22Stupin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deenadayalan%22%2C%22lastName%22%3A%22Bakthavatsalam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20V.%22%2C%22lastName%22%3A%22Market%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20T.%22%2C%22lastName%22%3A%22Willerson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ananth%20V.%22%2C%22lastName%22%3A%22Annapragada%22%7D%5D%2C%22abstractNote%22%3A%22Inflammation%20drives%20the%20degradation%20of%20atherosclerotic%20plaque%2C%20yet%20there%20are%20no%20non-invasive%20techniques%20available%20for%20imaging%20overall%20inflammation%20in%20atherosclerotic%20plaques%2C%20especially%20in%20the%20coronary%20arteries.%20To%20address%20this%2C%20we%20have%20developed%20a%20clinically%20relevant%20system%20to%20image%20overall%20inflammatory%20cell%20burden%20in%20plaque.%20Here%2C%20we%20describe%20a%20targeted%20contrast%20agent%20%28THI0567-targeted%20liposomal-Gd%29%20that%20is%20suitable%20for%20magnetic%20resonance%20%28MR%29%20imaging%20and%20binds%20with%20high%20affinity%20and%20selectivity%20to%20the%20integrin%20%5Cu03b14%5Cu03b21%28very%20late%20antigen-4%2C%20VLA-4%29%2C%20a%20key%20integrin%20involved%20in%20recruiting%20inflammatory%20cells%20to%20atherosclerotic%20plaques.%20This%20liposomal%20contrast%20agent%20has%20a%20high%20T1%20relaxivity%20%28~2%5Cu2009%5Cu00d7%5Cu2009105%5Cu2009mM-1s-1%20on%20a%20particle%20basis%29%20resulting%20in%20the%20ability%20to%20image%20liposomes%20at%20a%20clinically%20relevant%20MR%20field%20strength.%20We%20were%20able%20to%20visualize%20atherosclerotic%20plaques%20in%20various%20regions%20of%20the%20aorta%20in%20atherosclerosis-prone%20ApoE-%5C%2F-%20mice%20on%20a%201%20Tesla%20small%20animal%20MRI%20scanner.%20These%20enhanced%20signals%20corresponded%20to%20the%20accumulation%20of%20monocyte%5C%2Fmacrophages%20in%20the%20subendothelial%20layer%20of%20atherosclerotic%20plaques%20in%20vivo%2C%20whereas%20non-targeted%20liposomal%20nanoparticles%20did%20not%20demonstrate%20comparable%20signal%20enhancement.%20An%20inflammatory%20cell-targeted%20method%20that%20has%20the%20specificity%20and%20sensitivity%20to%20measure%20the%20inflammatory%20burden%20of%20a%20plaque%20could%20be%20used%20to%20noninvasively%20identify%20patients%20at%20risk%20of%20an%20acute%20ischemic%20event.%22%2C%22date%22%3A%22Feb%2027%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-018-21893-x%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NNUFWYNJ%22%2C%226MADD4J5%22%2C%22WGZKEVDQ%22%2C%22BBMMGS3D%22%2C%227XFQVVGN%22%2C%22JH9V95Q8%22%2C%22VXDM6BAE%22%2C%224R4R39JD%22%2C%227STYFUFZ%22%2C%225QIRWFUY%22%5D%2C%22dateModified%22%3A%222018-05-07T19%3A32%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22GECGZIMX%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kumar%20et%20al.%22%2C%22parsedDate%22%3A%222016-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKumar%2C%20V.%20A.%2C%20Liu%2C%20Q.%2C%20Wickremasinghe%2C%20N.%20C.%20et%20al.%20%282016%29.%20Treatment%20of%20hind%20limb%20ischemia%20using%20angiogenic%20peptide%20nanofibers.%20%26lt%3Bi%26gt%3BBiomaterials%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B98%26lt%3B%5C%2Fi%26gt%3B%2C%20113%26%23x2013%3B119.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.biomaterials.2016.04.032%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.biomaterials.2016.04.032%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20of%20hind%20limb%20ischemia%20using%20angiogenic%20peptide%20nanofibers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivek%20A.%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Navindee%20C.%22%2C%22lastName%22%3A%22Wickremasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siyu%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toya%20T.%22%2C%22lastName%22%3A%22Cornwright%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuxiao%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alon%22%2C%22lastName%22%3A%22Azares%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20N.%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20M.%22%2C%22lastName%22%3A%22Acevedo-Jake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noel%20R.%22%2C%22lastName%22%3A%22Agudo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20T.%22%2C%22lastName%22%3A%22Willerson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20D.%22%2C%22lastName%22%3A%22Hartgerink%22%7D%5D%2C%22abstractNote%22%3A%22For%20a%20proangiogenic%20therapy%20to%20be%20successful%2C%20it%20must%20promote%20the%20development%20of%20mature%20vasculature%20for%20rapid%20reperfusion%20of%20ischemic%20tissue.%20Whole%20growth%20factor%2C%20stem%20cell%2C%20and%20gene%20therapies%20have%20yet%20to%20achieve%20the%20clinical%20success%20needed%20to%20become%20FDA-approved%20revascularization%20therapies.%20Herein%2C%20we%20characterize%20a%20biodegradable%20peptide-based%20scaffold%20engineered%20to%20mimic%20VEGF%20and%20self-assemble%20into%20a%20nanofibrous%2C%20thixotropic%20hydrogel%2C%20SLanc.%20We%20found%20that%20this%20injectable%20hydrogel%20was%20rapidly%20infiltrated%20by%20host%20cells%20and%20could%20be%20degraded%20while%20promoting%20the%20generation%20of%20neovessels.%20In%20mice%20with%20induced%20hind%20limb%20ischemia%2C%20this%20synthetic%20peptide%20scaffold%20promoted%20angiogenesis%20and%20ischemic%20tissue%20recovery%2C%20as%20shown%20by%20Doppler-quantified%20limb%20perfusion%20and%20a%20treadmill%20endurance%20test.%20Thirteen-month-old%20mice%20showed%20significant%20recovery%20within%207%20days%20of%20treatment.%20Biodistribution%20studies%20in%20healthy%20mice%20showed%20that%20the%20hydrogel%20is%20safe%20when%20administered%20intramuscularly%2C%20subcutaneously%2C%20or%20intravenously.%20These%20preclinical%20studies%20help%20establish%20the%20efficacy%20of%20this%20treatment%20for%20peripheral%20artery%20disease%20due%20to%20diminished%20microvascular%20perfusion%2C%20a%20necessary%20step%20before%20clinical%20translation.%20This%20peptide-based%20approach%20eliminates%20the%20need%20for%20cell%20transplantation%20or%20viral%20gene%20transfection%20%28therapies%20currently%20being%20assessed%20in%20clinical%20trials%29%20and%20could%20be%20a%20more%20effective%20regenerative%20medicine%20approach%20to%20microvascular%20tissue%20engineering.%22%2C%22date%22%3A%22Aug%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.biomaterials.2016.04.032%22%2C%22ISSN%22%3A%221878-5905%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NNUFWYNJ%22%2C%22WGZKEVDQ%22%2C%22BBMMGS3D%22%2C%227XFQVVGN%22%2C%22LV239TYN%22%2C%22UWW3ZRC2%22%2C%22CH4JXISP%22%5D%2C%22dateModified%22%3A%222018-05-02T21%3A21%3A07Z%22%7D%7D%5D%7D
Guan, Y.-S., Ershad, F., Rao, Z. et al. (2022). Elastic electronics based on micromesh-structured rubbery semiconductor films. Nat Electron. https://doi.org/10.1038/s41928-022-00874-z.
Mendiola, E. A., Neelakantan, S., Xiang, Q. et al. (2022). Contractile adaptation of the left ventricle post-myocardial infarction: predictions by rodent-specific computational modeling. Ann Biomed Eng. https://doi.org/10.1007/s10439-022-03102-z.
Hickman, A., Koetsier, J., Kurtanich, T. et al. (2022). LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade. J Clin Invest 132, e154152. https://doi.org/10.1172/JCI154152.
Babaei, H., Mendiola, E. A., Neelakantan, S. et al. (2022). A machine learning model to estimate myocardial stiffness from EDPVR. Sci Rep 12, 5433. https://doi.org/10.1038/s41598-022-09128-6.
Lokugamage, N., Chowdhury, I. H., Biediger, R. J. et al. (2021). Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease. NPJ Vaccines 6, 114. https://doi.org/10.1038/s41541-021-00378-5.
Bakthavatsalam, D., Craft, J. W., Kazansky, A. et al. (2020). Identification of Inhibitors of Integrin Cytoplasmic Domain Interactions With Syk. Front Immunol 11, 575085. https://doi.org/10.3389/fimmu.2020.575085.
Avazmohammadi, R., Mendiola, E., Li, D. et al. (2019). Interactions between structural remodeling and volumetric growth in right ventricle in response to pulmonary arterial hypertension. J Biomech Eng. https://doi.org/10.1115/1.4044174.
Avazmohammadi, R., Mendiola, E. A., Soares, J. S. et al. (2019). A computational cardiac model for the adaptation to pulmonary arterial hypertension in the rat. Ann Biomed Eng 47, 138–153. https://doi.org/10.1007/s10439-018-02130-y.
Woodside, D. G., Tanifum, E. A., Ghaghada, K. B. et al. (2018). Magnetic resonance imaging of atherosclerotic plaque at clinically relevant field strengths (1T) by targeting the integrin α4β1. Sci Rep 8, 3733. https://doi.org/10.1038/s41598-018-21893-x.
Kumar, V. A., Liu, Q., Wickremasinghe, N. C. et al. (2016). Treatment of hind limb ischemia using angiogenic peptide nanofibers. Biomaterials 98, 113–119. https://doi.org/10.1016/j.biomaterials.2016.04.032.

Recent News

See All

7 Hills Pharma Announces First Patient in Phase 1b/2a Clinical Trial Testing Alintegimod Against aPD-1-resistant Solid Tumors

The Texas Heart Institute is excited to share the groundbreaking progress of 7 Hills Pharma Inc. (“7 Hills”), a clinical-stage...

Read more

A Discovery by The Texas Heart Institute & 7 Hills Pharma Continues Development under a $4.7 Million CPRIT Grant to Address Cancer Treatment Disparities

Peter Vanderslice, PhD, Senior Investigator and Director, MCRL, Molecular Cardiology Research, was highlighted in a recent announcement from 7 Hills Pharma,...

Read more

Scientists have found a beautiful way to amplify vaccines

A technology platform co-invented by scientists at The Texas Heart Institute in partnership with 7 Hills Pharma CEO and co-founder...

Read more